Nuvectra Corporation

NVTRQ

US67075N1081

Medical Equipment, Supplies & Distribution

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		+16.67%	-85.26%

2020	Nuvectra Corporation Went Out of Business	CI
2020	Second Amended Liquidation Plan Approved for Nuvectra Corporation	CI

Nuvectra Corporation Announces the Resignation of J. Paul Hanchin as President

June 28, 2019 at 10:00 pm

On June 27, 2019, Nuvectra Corporation and J. Paul Hanchin, the President of the Company, mutually agreed to Mr. Hanchin's separation of employment from the Company, effective as of June 27, 2019.

Latest news about Nuvectra Corporation

Nuvectra Corporation Went Out of Business	02/06/20	CI
Second Amended Liquidation Plan Approved for Nuvectra Corporation	21/05/20	CI
Second Amended Liquidation Plan Filed by Nuvectra Corporation	18/05/20	CI
Motion for Asset Sale Approved for Nuvectra Corporation	09/03/20	CI
First Amended Disclosure Statement Approved for Nuvectra Corporation	06/03/20	CI
First Amended Liquidation Plan and Disclsoure Statement Filed by Nuvectra Corporation	05/03/20	CI
Notice of Selection of Successful Bidder Filed for Nuvectra Corporation	28/02/20	CI
Liquidation Plan and Disclosure Statement Filed by Nuvectra Corporation	29/01/20	CI
Bidding Procedure Approved for Nuvectra Corporation	13/01/20	CI
Motion for Asset Sale Filed by Nuvectra Corporation	20/12/19	CI
Nuvectra Corporation Announces Reduction in Force; Announces Board Changes	22/11/19	CI
Nuvectra Corporation(NasdaqGM:NVTR) dropped from NASDAQ Composite Index	21/11/19	CI
Nuvectra Corporation(NasdaqGM:NVTR) dropped from S&P TMI Index	15/11/19	CI
Nuvectra Corporation Filed for Bankruptcy	12/11/19	CI
Nuvectra Corporation Submits Chemical Composition and Biocompatibility Data to FDA for Virtis	18/10/19	CI
Nuvectra Corporation(NasdaqGM:NVTR) dropped from S&P Global BMI Index	23/09/19	CI
Nuvectra Corporation Names Jennifer J. Kosharek as Executive Vice President and Chief Financial Officer, Effective September 16, 2019	20/09/19	CI
Nuvectra Explores Strategic Options	26/08/19	CI
Transcript : Nuvectra Corporation, Q2 2019 Earnings Call, Jul 31, 2019	31/07/19
Nuvectra Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2019	31/07/19	CI
Nuvectra Corporation Revises Revenues Guidance for 2019	31/07/19	CI
Nuvectra Corporation Announces Resignation of J. Paul Hanchin as President	10/07/19	CI
Nuvectra Corporation Announces the Resignation of J. Paul Hanchin as President	28/06/19	CI
Nuvectra Corporation(OTCPK:NVTR.Q) dropped from Russell 2000 Dynamic Index	28/06/19	CI
Nuvectra Files Regulatory Submission with FDA for Algovita Full-Body MR-Conditional Approval	11/06/19	CI

Nuvectra Corporation is a neurostimulation company that focuses on helping physicians to improve the lives of people with chronic neurological conditions. The Company's Algovita Spinal Cord Stimulation (SCS) System (Algovita) is the Company's commercial offering and is Conformite Europeene (CE) marked and the United States Food and Drug Administration (FDA) approved for the treatment of chronic pain of the trunk and/or limbs. Its technology platform also has capabilities under development to support other neurological indications, such as sacral nerve stimulation (SNS) and deep brain stimulation (DBS). In addition, its NeuroNexus Technologies, Inc. (NeuroNexus) subsidiary designs, manufactures and markets neural-interface technologies for the neuroscience clinical research market. Its Virtis is an application of the Company's neurostimulation technology platform and its first product for the SNS market. Its subsidiaries include Algostim, LLC (Algostim) and PelviStim LLC (PelviStim).

Sector

Medical Equipment, Supplies & Distribution

More about the company

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
NUVECTRA CORPORATION	-85.26%	268K
ABBOTT LABORATORIES	-5.31%	182B
MEDTRONIC PLC	-1.21%	114B
BECTON, DICKINSON AND COMPANY	-5.53%	67.76B
DEXCOM, INC.	+1.22%	51.91B
CENCORA, INC.	+7.03%	43.23B
HOYA CORPORATION	+6.07%	41.07B
METTLER-TOLEDO INTERNATIONAL, INC.	+21.96%	32.07B
TERUMO CORPORATION	+15.86%	25B
ZIMMER BIOMET HOLDINGS, INC.	-4.81%	24.55B

Other Medical Equipment, Supplies & Distribution